BL Pharmtech Corp. (KOSDAQ:065170)

BL Pharmtech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	144,867	20,819	44,929	55,605	116,549	145,716
Market Cap Growth	688.52%	-53.66%	-19.20%	-52.29%	-20.02%	65.77%
Enterprise Value	147,796	25,570	86,785	100,284	144,445	185,313
Last Close Price	5430.00	780.00	1683.33	2083.33	4366.67	5583.33
PS Ratio	20.76	2.36	1.83	2.47	1.38	2.22
PB Ratio	6.66	0.86	1.41	1.35	1.78	2.00
P/TBV Ratio	6.69	0.87	1.46	2.26	2.66	4.13
P/FCF Ratio	124.40	-	5.85	-	46.44	-
P/OCF Ratio	124.40	-	5.62	-	37.64	25.11
EV/Sales Ratio	21.18	2.90	3.54	4.45	1.71	2.82
EV/EBITDA Ratio	-	-	-	-	-	394.74
EV/FCF Ratio	126.91	-	11.30	-	57.56	-
Debt / Equity Ratio	0.24	0.25	0.13	1.04	0.64	0.60
Debt / EBITDA Ratio	-	-	-	-	-	93.61
Debt / FCF Ratio	4.42	-	0.56	-	16.69	-
Net Debt / Equity Ratio	0.13	0.09	-0.28	0.91	0.29	0.43
Net Debt / EBITDA Ratio	-0.80	-0.64	1.43	-9.56	-130.44	67.24
Net Debt / FCF Ratio	2.49	-0.53	-1.16	-2.93	7.63	-2.67
Asset Turnover	0.19	0.22	0.33	0.19	0.64	0.59
Inventory Turnover	2.46	1.64	1.32	0.87	6.68	5.12
Quick Ratio	0.32	0.73	1.79	0.34	0.90	0.71
Current Ratio	0.60	1.05	2.12	0.67	1.14	1.09
Return on Equity (ROE)	-24.23%	-20.39%	-37.90%	-27.09%	-29.05%	-26.79%
Return on Assets (ROA)	-7.44%	-6.68%	-5.99%	-2.56%	-1.70%	-1.15%
Return on Invested Capital (ROIC)	-17.47%	-17.60%	-14.08%	-5.88%	-3.80%	-2.64%
Return on Capital Employed (ROCE)	-18.80%	-14.60%	-19.30%	-8.80%	-3.90%	-2.00%
Earnings Yield	-4.15%	-27.41%	-0.33%	-25.00%	-17.34%	-12.32%
FCF Yield	0.80%	-20.19%	17.09%	-22.85%	2.15%	-8.11%
Buyback Yield / Dilution	0.43%	-	0.00%	-1.33%	-18.44%	-19.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.